» Articles » PMID: 34209187

Maternal Systemic Lupus Erythematosus (SLE) High Risk for Preterm Delivery and Not for Long-Term Neurological Morbidity of the Offspring

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Jul 2
PMID 34209187
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Pregnancies of women with systemic lupus erythematosus (SLE) are associated with preterm delivery. As preterm delivery is associated with long-term neurological morbidity, we opted to evaluate the long-term neurologic outcomes of offspring born to mothers with SLE regardless of gestational age.

Methods: Perinatal outcomes and long-term neurological disease of children of women with and without SLE during pregnancy were evaluated. Children of women with and without SLE were followed until 18 years of age for neurological diseases. Generalized estimating equation (GEE) models were used to assess perinatal outcomes. To compare cumulative neurological morbidity incidence a Kaplan-Meier survival curve was used, and a Cox proportional hazards model was used to control for confounders.

Result: A total of 243,682 deliveries were included, of which 100 (0.041%) were of women with SLE. Using a GEE model, maternal SLE was noted as an independent risk factor for preterm delivery. The cumulative incidence of long-term neurological disease was not found to be significantly higher when using the Kaplan Meier survival curves and maternal SLE was not found to be associated with long-term neurological disease of the offspring when a Cox model was used.

Conclusion: Despite the association of SLE with preterm delivery, no difference in long-term neurological disease was found among children of women with or without SLE.

Citing Articles

Effects of perinatal disease activity on offspring's growth in patients with systemic lupus erythematosus.

Wei Y, Zhu Y, Tang J, Li J, Wang Z, Jin Z Arch Med Sci. 2024; 20(4):1171-1179.

PMID: 39439694 PMC: 11493028. DOI: 10.5114/aoms/154929.


Systemic Lupus Erythematosus and Pregnancy Complications and Outcomes: A Mendelian Randomization Study and Retrospective Validation.

Zhu S, Ren J, Feng L, Jiang Y Int J Womens Health. 2024; 16:891-902.

PMID: 38779383 PMC: 11110830. DOI: 10.2147/IJWH.S461640.


Female Infertility in Chronic Kidney Disease.

Bhaduri M, Sarris I, Bramham K Diagnostics (Basel). 2023; 13(20).

PMID: 37892037 PMC: 10606530. DOI: 10.3390/diagnostics13203216.


A Comprehensive Literature Review on Managing Systemic Lupus Erythematosus: Addressing Cardiovascular Disease Risk in Females and Its Autoimmune Disease Associations.

Dar S, Koirala S, Khan A, Bellary M, Patel A, Mathew B Cureus. 2023; 15(8):e43725.

PMID: 37727166 PMC: 10505685. DOI: 10.7759/cureus.43725.


[Research progress on long-term developmental outcomes of offspring of pregnant women with systemic lupus erythematosus].

Shao S, Zhang Y, Zhang X Zhongguo Dang Dai Er Ke Za Zhi. 2023; 25(4):415-419.

PMID: 37073848 PMC: 10120341. DOI: 10.7499/j.issn.1008-8830.2211036.


References
1.
Heard A, Dekker G, Chan A, Jacobs D, Vreeburg S, Priest K . Hypertension during pregnancy in South Australia, part 1: pregnancy outcomes. Aust N Z J Obstet Gynaecol. 2004; 44(5):404-9. DOI: 10.1111/j.1479-828X.2004.00267.x. View

2.
Nalli C, Iodice A, Andreoli L, Galli J, Lojacono A, Motta M . Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome. Lupus. 2017; 26(5):552-558. DOI: 10.1177/0961203317694960. View

3.
Wahren-Herlenius M, Sonesson S . Specificity and effector mechanisms of autoantibodies in congenital heart block. Curr Opin Immunol. 2006; 18(6):690-6. DOI: 10.1016/j.coi.2006.09.012. View

4.
Maducolil M, Al-Obaidly S, Olukade T, Salama H, AlQubaisi M, Rifai H . Maternal characteristics and pregnancy outcomes of women with chronic hypertension: a population-based study. J Perinat Med. 2019; 48(2):139-143. DOI: 10.1515/jpm-2019-0293. View

5.
Wang L, Zhou D, Lee J, Niu H, Faust T, Frattini S . Female mouse fetal loss mediated by maternal autoantibody. J Exp Med. 2012; 209(6):1083-9. PMC: 3371726. DOI: 10.1084/jem.20111986. View